TICKERNERD
Menu
HUMHUMHealthcare · Healthcare Plans

HUM Stock Forecast: Humana, Inc. Price Predictions for 2026-2027

Last close, 3 Sept 2026
$407
+1.38% on the day

The 26 Wall Street analysts covering Humana, Inc. hold a median 12-month price target of $415 — +2.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 46 of 100 as at 2 Sept 2026 — in the lower half.

Market cap
$48.1B
Ticker Nerd rank
46 / 100
Median analyst target
$415
Analysts covering
26
Revenue$40.9B+26.2% y/y
Net income$693.0M
Free cash flow$1.8B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+3.5%
1M
+8.6%
YTD
+59.9%
1Y
+32.2%
From 52W high
−0.7%
From 52W low
+150.2%
$162
$409
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HUM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Humana, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Sept 2026
46 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
90
Volatility
79
Value
65
Revisions
57
Growth
53
Issuance
52
Accruals
34
Quality
31
Size
5

Momentum (90): The shares have been drifting up relative to others.

Quality (31): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HUM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HUM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$200$300$400$500Oct 25Jan 26Apr 26Jul 26HUMHigh $513Median $415Low $280

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says26 analysts
12 Buy13 Hold1 Sell
Low $280Median $415High $513

The green dot is the last close — the median target sits +2.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 10 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
10 Aug 2026JP MorganMaintainsNeutral$316 → $393
5 Aug 2026Morgan StanleyUpgradeEqual-Weight$249 → $370
31 July 2026BarclaysMaintainsEqual-Weight$344 → $407
31 July 2026BarclaysMaintainsEqual-Weight—
31 July 2026TD CowenMaintainsHold$350 → $370
31 July 2026TD CowenMaintainsHold—
30 July 2026Evercore ISI GroupUpgradeOutperform—
30 July 2026Evercore ISI GroupUpgradeOutperform$430 → $480
30 July 2026GuggenheimMaintainsBuy$269 → $471
30 July 2026GuggenheimMaintainsBuy—
30 July 2026Raymond JamesDowngradeMarket Perform—
30 July 2026Raymond JamesDowngradeMarket Perform—
30 July 2026UBSMaintainsNeutral—
30 July 2026UBSMaintainsNeutral$320 → $405
14 July 2026TD CowenMaintainsHold—
14 July 2026TD CowenMaintainsHold$211 → $350
14 July 2026Truist SecuritiesMaintainsHold—
14 July 2026Truist SecuritiesMaintainsHold$320 → $415
13 July 2026Wells FargoUpgradeOverweight—
13 July 2026Wells FargoUpgradeOverweight$227 → $502

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HUM appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HUM vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 3 Sept 2026, Humana, Inc. returned +32.2% against +21.4% for the S&P 500, dividends included.

HUM vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140Oct 25Jan 26Apr 26Jul 26HUMS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HUM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+3.5%
Analysts raising
11
Analysts cutting
4
Fundamentals

Humana, Inc. (HUM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
38.9×

Cheaper than 21% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
2.6×

Cheaper than 40% of US stocks

EV / EBITDA
10.9×

Cheaper than 37% of US stocks

Growth & margins
Revenue growth (YoY)
26.2%

Higher than 76% of US stocks

Earnings growth (YoY)
27.3%

Higher than 64% of US stocks

Gross margin
—
Operating margin
3.5%

Higher than 51% of US stocks

Net margin
0.9%

Higher than 49% of US stocks

Returns & dividend
Return on equity
6.9%

Higher than 57% of US stocks

Return on assets
3.9%

Higher than 70% of US stocks

Dividend yield
0.9%

Higher than 20% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Humana, Inc. (HUM) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Humana, Inc. has a market value of $48.1B and an enterprise value of $39.1B.

  • Revenue in the twelve months to 30 June 2026: $145.7B. The latest quarter grew 26.2% year on year.

  • Net income over the same four quarters: $1.3B, a 0.9% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $1.9B.

  • Humana, Inc. spent $150.0M on share buybacks and $430.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 120.1M.

  • Trailing P/E: 38.9×; forward P/E: 24.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.86%, paying out 33% of earnings.

  • Humana, Inc. employs 67,060 people — $2.2M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Sept 2026

Data provided by Twelve Data

Peers

HUM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
HUMHumana, Inc.$48.1B
46
CNCCentene Corp.$33.1B
94
CIThe Cigna Group$74.7B
71
ELVElevance Health, Inc.$90.2B
68
CVSCVS Health Corp.$123.4B
87
MOHMolina Healthcare, Inc.$10.4B
33
OSCROscar Health, Inc.$9.0B
85

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Humana, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HUM news & analysis

Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition

Business Wire · 3 Sept 2026positive

Humana announced it has earned the 2026 Great Place To Work Certification™ and the PEOPLE Companies That Care® recognition. This acknowledgment highlights the company's workplace culture and employee-focused practices.

Why it matters — Workplace recognitions like these can support Humana's ability to attract and retain talent, which is relevant to its long-term operational stability.

Humana Board Declares Payment of Quarterly Dividend to Stockholders

Business Wire · 2 Sept 2026neutral

Humana Inc. announced that its Board of Directors has declared a cash dividend of $0.885 per share, payable on November 27, 2026, to stockholders of record as of October 30, 2026.

Why it matters — The declared dividend provides shareholders with a scheduled return on their investment and signals the company's routine capital-distribution activity.

Humana Foundation Names 2026 Scholarship Recipients

Business Wire · 1 Sept 2026neutral

The Humana Foundation, Humana Inc.'s philanthropic arm, announced 80 winners of college scholarships through its Humana Foundation Scholarship Program. The scholarships provide up to $3,000 per year, renewable for up to three years, for postsecondary education of children of Humana employees.

Why it matters — This item highlights Humana Foundation's employee-support and community engagement activities, which may be of interest to Humana watchers tracking the company's philanthropic and workforce initiatives.

Why Is Humana (HUM) Up 7.1% Since Last Earnings Report?

Zacks Investment Research · 28 Aug 2026positive

Humana's stock has risen 7.1% since it reported earnings 30 days ago. The report notes the earnings release and raises the question of what may come next for the company's shares.

Why it matters — Humana watchers would care because the article tracks how the stock has performed in the month after its latest earnings report and considers the outlook ahead.

Here's Why Investors Should Retain Humana Stock for Now

Zacks Investment Research · 26 Aug 2026neutral

Zacks advises investors to retain Humana (HUM) stock for now, citing growth from Medicare Advantage, expansion of its CenterWell business, and strong cash generation, while noting that rising costs and debt remain concerns.

Why it matters — A HUM watcher would care because the report balances the company's key growth drivers with the cost and debt pressures that could affect its performance.

FAQ

Frequently asked questions about HUM stock

What is the HUM stock price forecast for 2026-2027?

The 26 Wall Street analysts covering Humana, Inc. have a median 12-month price target of $415, with estimates ranging from $280 to $513. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HUM stock a buy right now?

Of the 26 analysts covering Humana, Inc., 12 rate it a Buy, 13 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Humana, Inc. 46 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HUM?

As at 2 Sept 2026, Humana, Inc. ranks 46 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (90 of 100).

Will HUM stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +2.1% from the last close, and Ticker Nerd's factor model ranks Humana, Inc. 46 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HUM stock forecast for 2030?

No analyst covering Humana, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HUM are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $280 to $513 over the next 12 months.

How has HUM stock performed over the past year?

Humana, Inc. returned +32.2% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Humana, Inc. do?

Humana Inc. is a managed healthcare company that provides health insurance and healthcare services across the United States.

What is the latest news on HUM?

The most recent item we track (Business Wire, 3 Sept 2026): "Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition". Humana announced it has earned the 2026 Great Place To Work Certification™ and the PEOPLE Companies That Care® recognition. This acknowledgment highlights the company's workplace culture and employee-focused practices.

Company

About Humana, Inc.

Humana Inc. is a managed healthcare company that provides health insurance and healthcare services across the United States. Its core offerings include Medicare Advantage plans, stand-alone prescription drug coverage, Medicare Supplement products, Medicaid-related plans, specialty benefits such as dental, vision, life and disability coverage, and employer group health plans. Through its CenterWell segment, Humana also delivers primary care, pharmacy services, and home-based care, supporting more integrated care for older adults and other members with ongoing health needs. The company serves individuals, families, employers, and government program participants, with a strong focus on Medicare-eligible populations and care coordination. Headquartered in Louisville, Kentucky, Humana plays a significant role in the U.S. managed care market by combining insurance coverage with healthcare delivery services.

CEO Mr. James A. Rechtin M.B.A. · 67,060 employees · United States · https://www.humana.com